An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology.
Epinephrine (Adrenaline) auto-injectors are latest trend in the market and are used for the treatment of anaphylaxis which occurs in people suffering from cardiac arrest, allergy and asthma.
One major driver for this market growth has been the increasing ubiquity of allergies amongst people.
In 2018, the global Epinephrine Auto-Injectors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Epinephrine Auto-Injectors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epinephrine Auto-Injectors development in United States, Europe and China.
The key players covered in this study
Amedra Pharmaceuticals LLC
Market segment by Type, the product can be split into
Market segment by Application, split into
Liquid food injection
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Epinephrine Auto-Injectors status, future forecast, growth opportunity, key market and key players.
To present the Epinephrine Auto-Injectors development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Epinephrine Auto-Injectors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.